Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Operating expenses:
Research and development	$ 17,073	$ 9,849
General and administrative	7,674	4,359
Total operating expenses	24,747	14,208
Loss from operations	(24,747)	(14,208)
Interest income	225	25
Other income (expense), net	(11)	(2)
Net loss	$ (24,533)	$ (14,185)
Net loss per share , basic and diluted	$ (0.60)	$ (0.35)
Weighted-average shares of common stock used to compute net loss per shares, basic and diluted	40,616,302	40,055,435